
CAR-T Therapy in India: A New Hope for CancerCAR-T cell therapy is a breakthrough cancer treatment that uses a patient’s own immune cells, re-engineered in a lab, to target and destroy cancer cells. It offers new hope for patients with advanced or treatment-resistant blood cancers. Medico Solutions connects you with India’s leading CAR-T experts, ensuring access to world-class treatment, advanced labs, and personalized care. Our Expertise Areas Acute Lymphoblastic Leukemia (ALL) Effective therapy for relapsed or refractory ALL patients. Diffuse Large B-Cell Lymphoma (DLBCL) Advanced treatment for aggressive forms of non-Hodgkin lymphoma. Multiple Myeloma (Select Cases) Promising option for patients with resistant or recurrent myeloma. Pediatric Leukemia (B-ALL) Specialized care for children diagnosed with B-cell acute lymphoblastic leukemia. Personalized Immunotherapy Tailored CAR-T treatment designed to match each patient’s condition. Access to Cutting-Edge Research Trials Opportunities for eligible patients to join global CAR-T clinical studies.
